MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

Search

DexCom Inc

Closed

SectorHealthcare

70.74 5.46

Overview

Share price change

24h

Current

Min

66.81

Max

70.94

Key metrics

By Trading Economics

Income

17M

152M

Sales

119M

1.1B

P/E

Sector Avg

46.556

57.333

EPS

0.45

Profit margin

13.624

Employees

10,200

EBITDA

5M

242M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+49.48% upside

Dividends

By Dow Jones

Next Earnings

1 maj 2025

Market Stats

By TradingEconomics

Market Cap

-8.4B

26B

Previous open

65.28

Previous close

70.74

Technical Score

By Trading Central

Confidence

Bullish Evidence

DexCom Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

25 paź 2024, 09:10 UTC

Earnings

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

26 lip 2024, 20:16 UTC

Earnings

These Stocks Moved the Most Today: DexCom, 3M, Nvidia, Bristol Myers, Coursera, Biogen, Charter, Deckers, and More -- Barrons.com

26 lip 2024, 09:13 UTC

Top News
Hot Stocks

Stocks to Watch: DexCom, Coinbase, 3M, Hermès -- WSJ

26 lip 2024, 08:56 UTC

Top News

These Stocks Are Moving the Most Today: DexCom, Deckers, Coursera, Ford, Alphabet, Bristol Myers, 3M, and More -- Barrons.com

27 cze 2024, 16:01 UTC

Earnings

ResMed Stock Is Down Because of GLP-1 Concerns. It Shouldn't Be. -- Barrons.com

Peer Comparison

Price change

DexCom Inc Forecast

Price Target

By TipRanks

49.48% upside

12 Months Forecast

Average 99.94 USD  49.48%

High 115 USD

Low 82 USD

Based on 19 Wall Street analysts offering 12 month price targets forDexCom Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

19 ratings

17

Buy

2

Hold

0

Sell

Technical Score

By Trading Central

66.46 / 68.73Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Very Strong Bearish Evidence

Long Term

Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About DexCom Inc

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.